DistantNews
Support us

Greek medicines agency warns against illegally marketed supplement linked to serious health risks

From Ta Nea · () Greek

Translated from Greek and summarized by DistantNews. Read the original for the full story.

At a glance

News Official statement Ongoing story
  • Greece’s National Organization for Medicines warned consumers not to buy or use WELLNEXIS SUPER COMPLEX, which is being advertised and distributed illegally online.
  • The product makes claims about erectile dysfunction, joint pain and swelling, and cardiovascular health, but it is neither an approved medicine nor a supplement notified to the agency.
  • The agency said the product’s safety and effectiveness have not been evaluated and asked anyone who possesses it not to use it and to notify authorities.

Greece’s National Organization for Medicines, known as EOF, has issued a warning about WELLNEXIS SUPER COMPLEX, a dietary supplement promoted and distributed illegally over the internet.

The agency urged consumers not to obtain or use the product. The company allegedly responsible for bringing it to the Greek market or distributing it remains unknown, while the product is being promoted through websites operating unlawfully.

Online advertisements claim that WELLNEXIS SUPER COMPLEX can help treat erectile dysfunction, relieve joint pain and swelling, and support cardiovascular health. EOF said the product is not an approved medicinal product and has not been notified to the agency as a dietary supplement.

Its safety and effectiveness therefore have not been assessed by EOF. The agency warned consumers to be particularly cautious about products advertised online with therapeutic or other claims without the required approval or notification.

Anyone who already has WELLNEXIS SUPER COMPLEX should not use it and should inform EOF immediately, the agency said.

About this summary

Originally published by Ta Nea in Greek. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.